Orthobiologics Market Analysis, Size, Trends | India | 2020-2026 | MedSuite
- Year: 2020
- Scope: 2016-2026
- Region: India
- Pages: 267
- Published Date: 02/14/2020
- Type: MedSuite
By 2020, the Indian orthobiologics market size was valued at $76.2 million, with over 520,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 12.4% to reach $172.3 million in 2026.
Throughout this medical market research, we analyzed 23 orthobiologics companies across India and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.
While this MedSuite report contains all of the Indian Orthopedic Biomaterials market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Orthobiologics Procedure Volumes
- Market Forecasts Until 2026, and Historical Data to 2016
- Competitive Analysis with Market Shares for Each Segment
- Market Drivers & Limiters for Each Orthopedic Biomaterials Device market
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Market Value and Industry Trends
The first bone bank opened in India only in 1997, as compared to 1949 in China. In 2019, the majority of the allograft and DBM allograft supply in India was controlled by two local bone banks, TMH Tissue Bank and Ramaiah Tissue Bank. Other institutions have attempted to open bone banks in the past but have largely been unsuccessful. While the overall trend is positive, the adoption rate is still low, thus limiting the supply side of the market.
Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. In 2019, over 6% of India were aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65.
Although three-injection products were available in India before single-injection products, the benefits of the latter are typically perceived to outweigh the favorable cost of the former. As a result, single-injection products are expected to continue to cannibalize three-injection products over the forecast period. Due to the premium price of single-injection of products, this will stimulate the total HA viscosupplementation market.
In 2019, the leading competitor in the Indian orthopedic biomaterials market was Sanofi, which was solely attributed to its leading position in the HA viscosupplementation market. The company held the leading position in the single-injection market and the third-leading position in the three-injection market. Sanofi’s portfolio includes the single-injection Synvisc-One® and the three-injection Synvisc® product lines.
Fidia Farmaceutici was the second-leading competitor, which was also attributed to its position in the HA viscosupplementation market. The company held the second-leading position in the single-injection and three-injection markets and the fourth-leading position in the five-injection market. Fidia Farmaceutici’s portfolio includes the single-injection HYALONE® and the three-injection and five-injection HYALGAN® product line.
Click on each title to view more detailed market segmentation.
- Procedure Volumes for Orthopedic Biomaterials Devices – MedPro – The complete procedural analysis for each segment of the Indian Orthopedic Biomaterials market.
- Orthopedic Bone Graft Substitute Market – MedCore – This market is further segmented by Material Type, including Allograft, Demineralized Bone Matrix Allograft, and Synthetic. Each of these Material Types is segmented by Spine, Trauma, Large Joint Reconstruction, Craniomaxillofacial, and Oncology.
- Orthopedic Growth Factor Market – MedCore – In-depth analysis of the Orthopedic Growth Factor market.
- Hyaluronic Acid Viscosupplementation Market – MedCore – This market is categorized by Treatment Type, including Single-Injection, Three-Injection and Five-Injection.
Detailed Market Segmentation
DON’T SEE THE SEGMENT OR DATA YOU NEED?
Feel free to contact us or send a request by pressing one of the buttons below.
TABLE OF CONTENTS FOR THE INDIAN ORTHOPEDIC BIOMATERIALS MARKETTABLE OF CONTENTS ILIST OF FIGURES VIIILIST OF CHARTS XVEXECUTIVE SUMMARY 1INDIAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1COMPETITIVE ANALYSIS 3MARKET TRENDS 5MARKET DEVELOPMENTS 6PROCEDURE NUMBERS 7MARKETS INCLUDED 8KEY REPORT UPDATES 10VERSION HISTORY 10RESEARCH METHODOLOGY 11Step 1: Project Initiation & Team Selection 11Step 2: Prepare Data Systems and Perform Secondary Research 14Step 3: Preparation for Interviews & Questionnaire Design 16Step 4: Performing Primary Research 17Step 5: Research Analysis: Establishing Baseline Estimates 19Step 6: Market Forecast and Analysis 20Step 7: Identify Strategic Opportunities 22Step 8: Final Review and Market Release 23Step 9: Customer Feedback and Market Monitoring 24
PRODUCT ASSESSMENT2.1 INTRODUCTION 252.2 PRODUCT PORTFOLIOS 252.2.1 Bone Graft Substitutes 262.2.2 Growth Factors 322.214.171.124 Other Products 352.2.3 Hyaluronic Acid Viscosupplementation (HAV) 372.3 REGULATORY ISSUES AND RECALLS 402.3.1 Bone Graft Substitutes 402.3.1.1 Allografts 402.3.1.1.1 MTF 402.3.1.2 DBM 402.3.1.2.1 AlloSource 402.3.1.2.2 SeaSpine 4126.96.36.199.3 RTI Surgical 4188.8.131.52 Synthetics 4184.108.40.206.1 Abyrx 4220.127.116.11.2 Zimmer Biomet 422.3.2 Growth Factors 418.104.22.168.1 Medtronic 422.3.3 Hyaluronic Acid Viscosupplementation 422.214.171.124 Three-injection 4126.96.36.199.1 Ferring Pharmaceuticals 432.4 CLINICAL TRIALS 442.4.1 Bone Graft Substitutes 4188.8.131.52 Allografts 4184.108.40.206.1 Providence Medical Technology 4220.127.116.11.2 The University of Texas Health Science 418.104.22.168.3 University of Winchester 422.214.171.124 BDM 4126.96.36.199.1 K2M 4188.8.131.52.2 Zimmer Biomet 4184.108.40.206 Synthetics 4220.127.116.11.1 Baxter 418.104.22.168.2 Bonesupport 422.214.171.124.3 DePuy Synthes 4126.96.36.199.4 NuVasive 4188.8.131.52.5 RTI surgical 4184.108.40.206.6 Sunstar GUIDOR 502.4.1.4 Other materials and comparison 5220.127.116.11.1 Seoul National University Hospital. 518.104.22.168.2 Sewon Cellontech 522.214.171.124.3 SurgaColl Technologies Limited 5126.96.36.199.4 University of Colorado 5188.8.131.52.5 University of Padova 532.4.2 Growth Factors 5184.108.40.206.1 Bioventus 5220.127.116.11.2 Cerapedics 518.104.22.168.3 CGBio 522.214.171.124.4 Isto 5126.96.36.199.5 Medtronic 5188.8.131.52.6 NuVasive 5184.108.40.206.7 Wright 5220.127.116.11.8 Others 582.4.3 Hyaluronic Acid Viscosupplementation 518.104.22.168.1 Anika Therapeutics 522.214.171.124.2 Bioventus 602.4.3.1.3 Cairo University 6126.96.36.199.4 Ferring Pharmaceuticals 6188.8.131.52.5 Federal University of Minas Gerais 6184.108.40.206.6 Fidia Pharma USA Inc. 6220.127.116.11.7 Istituto Ortopedico Rizzoli 618.104.22.168.8 University Hospital 622.214.171.124.9 Universidade Nova de Lisboa 64
INDIAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW3.1 INTRODUCTION 653.1.1 Bone Graft Substitutes 653.1.2 Growth Factors 653.1.3 Hyaluronic Acid (HA) Viscosupplementation 663.2 CURRENCY EXCHANGE RATE 673.3 MARKET OVERVIEW AND TREND ANALYSIS 683.4 DRIVERS AND LIMITERS 763.4.1 Market Drivers 763.4.2 Market Limiters 763.5 COMPETITIVE MARKET SHARE ANALYSIS 783.6 MERGERS AND ACQUISITIONS 833.7 COMPANY PROFILES 853.7.1 Anika Therapeutics 853.7.2 Bioventus 863.7.3 DePuy Synthes 873.7.4 Ferring Pharmaceuticals 883.7.5 Fidia Pharmaceuticals 893.7.6 Genzyme (Sanofi Group) 903.7.7 Harvest Technologies (Terumo BCT) 913.7.8 Integra LifeSciences 923.7.9 Medtronic 933.7.10 Musculoskeletal Transplant Foundation (MTF) 953.7.11 NuVasive 963.7.12 Orthofix 973.7.13 RTI Surgical 983.7.14 Stryker 993.7.15 Vericel Corporation (formerly Aastrom Bioscience) 1003.7.16 Zimmer Biomet 1013.8 SWOT ANALYSIS 1033.8.1 Anika Therapeutics 1033.8.2 Bioventus 1053.8.3 DePuy Synthes 1073.8.4 Ferring Pharmaceuticals 1083.8.5 Fidia Pharmaceuticals 1093.8.7 Harvest Technologies (Terumo BCT) 1113.8.8 Integra LifeSciences 1123.8.9 Medtronic 1133.8.10 Musculoskeletal Transplant Foundation (MTF) 1143.8.11 NuVasive 1153.8.12 Orthofix 1163.8.14 Stryker 1183.8.15 Vericel Corporation (formerly Aastrom Bioscience) 1193.8.16 Zimmer Biomet 120
PROCEDURE NUMBERS4.1 INTRODUCTION 1224.1.1 Units per Procedure by Indication 1234.2 PROCEDURES 1244.2.1 Orthopedic Biomaterial Procedures by Segment 1244.2.2 Orthopedic Bone Grafting Procedures 12126.96.36.199 Orthopedic Bone Grafting Procedures by Material 12188.8.131.52.1 Autograft Procedures by Indication 12184.108.40.206.2 Allograft Procedures by Indication 13220.127.116.11.3 DBM Allograft Procedures by Indication 1318.104.22.168.4 Synthetic Procedures by Indication 1322.214.171.124 Orthopedic Bone Grafting Procedures by Indication 1404.2.3 Orthopedic Growth Factor Procedures 1434.2.4 Hyaluronic Acid Supplementation Procedures 14126.96.36.199 Hyaluronic Acid Supplementation Procedures by Injection Cycle 145
ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET5.1 INTRODUCTION 1475.2 MARKET OVERVIEW 1485.2.1 Orthopedic Bone Graft Substitute Market by Material 1485.2.2 Orthopedic Bone Graft Substitute Market by Indication 1535.3 MARKET ANALYSIS AND FORECAST 1595.3.1 Total Orthopedic Bone Graft Substitute Market 1595.3.2 Orthopedic Bone Graft Substitute Market by Material 16188.8.131.52 Allograft Bone Graft Substitute Market 16184.108.40.206.1 Allograft Bone Graft Substitute Market by Indication 16220.127.116.11 Demineralized Bone Matrix Allograft Bone Graft Substitute Market 1718.104.22.168.1 Demineralized Bone Matrix Allograft Bone Graft Substitute Market by Indication 1722.214.171.124 Synthetic Bone Graft Substitute Market 19126.96.36.199.1 Synthetic Bone Graft Substitute Market by Indication 1955.3.3 Orthopedic Bone Graft Substitute Market by Indication 2095.3.3.1 Spine Bone Graft Substitute Market 2095.3.3.2 Cervical Spine Bone Graft Substitute Market 2188.8.131.52 Thoracolumbar Spine Bone Graft Substitute Market 2184.108.40.206 Trauma Bone Graft Substitute Market 2220.127.116.11 Non-Union Trauma Bone Graft Substitute Market 218.104.22.168 Fresh Fracture Trauma Bone Graft Substitute Market 222.214.171.124 Large Joint Reconstruction Bone Graft Substitute Market 2126.96.36.199 Hip Reconstruction Bone Graft Substitute Market 2188.8.131.52 Knee Reconstruction Bone Graft Substitute Market 2255.3.3.10 Foot Reconstruction Bone Graft Substitute Market 22184.108.40.206 Craniomaxillofacial Bone Graft Substitute Market 22220.127.116.11 Oncology Bone Graft Substitute Market 2315.4 DRIVERS AND LIMITERS 2335.4.1 Market Drivers 2335.4.2 Market Limiters 2335.5 COMPETITIVE MARKET SHARE ANALYSIS 235
ORTHOPEDIC GROWTH FACTOR MARKET6.1 INTRODUCTION 2386.1.1 BMP-2 (Medtronic) 2386.2 MARKET ANALYSIS AND FORECAST 2406.3 DRIVERS AND LIMITERS 2426.3.1 Market Drivers 2426.3.2 Market Limiters 2426.4 COMPETITIVE MARKET SHARE ANALYSIS 244
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET7.1 INTRODUCTION 2457.1.1 Benefits of Viscosupplementation 2467.1.2 Synovial Fluid 2467.2 MARKET OVERVIEW 2477.3 MARKET ANALYSIS AND FORECAST 2537.3.1 Total Hyaluronic Acid Viscosupplementation Market 2537.3.2 Single-Injection Hyaluronic Acid Viscosupplementation Market 2557.3.3 Three-Injection Hyaluronic Acid Viscosupplementation Market 2577.3.4 Five-Injection Hyaluronic Acid Viscosupplementation Market 2597.4 DRIVERS AND LIMITERS 2617.4.1 Market Drivers 2617.4.2 Market Limiters 2617.5 COMPETITIVE MARKET SHARE ANALYSIS 263
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.